NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 254 filers reported holding NATERA INC in Q3 2020. The put-call ratio across all filers is 0.74 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,707,032 | +13.2% | 38,577 | +24.5% | 0.00% | 0.0% |
| Q2 2023 | $1,507,925 | -52.3% | 30,989 | -45.6% | 0.00% | -50.0% |
| Q1 2023 | $3,160,976 | +141.7% | 56,934 | +74.9% | 0.00% | +100.0% |
| Q4 2022 | $1,307,895 | -100.0% | 32,559 | -57.2% | 0.00% | -50.0% |
| Q2 2022 | $2,693,405,000 | -56.2% | 75,999 | -49.7% | 0.00% | -50.0% |
| Q1 2022 | $6,144,144,000 | +2640.1% | 151,036 | +6190.5% | 0.01% | – |
| Q4 2021 | $224,229,000 | -16.1% | 2,401 | +0.1% | 0.00% | – |
| Q3 2021 | $267,345,000 | +83.5% | 2,399 | +87.0% | 0.00% | – |
| Q2 2021 | $145,659,000 | -85.8% | 1,283 | -87.3% | 0.00% | -100.0% |
| Q1 2021 | $1,023,117,000 | -96.0% | 10,076 | -96.0% | 0.00% | -97.9% |
| Q4 2020 | $25,304,154,000 | +272.2% | 254,262 | +170.2% | 0.05% | +370.0% |
| Q3 2020 | $6,798,795,000 | +97.3% | 94,114 | +36.2% | 0.01% | +66.7% |
| Q2 2020 | $3,446,223,000 | -50.2% | 69,118 | -70.2% | 0.01% | -57.1% |
| Q1 2020 | $6,923,340,000 | +6.5% | 231,860 | +20.2% | 0.01% | +16.7% |
| Q4 2019 | $6,498,094,000 | +1849.2% | 192,879 | +1797.7% | 0.01% | +1100.0% |
| Q3 2019 | $333,379,000 | +143.7% | 10,164 | +104.9% | 0.00% | – |
| Q2 2019 | $136,797,000 | -16.0% | 4,960 | -37.2% | 0.00% | – |
| Q1 2019 | $162,877,000 | +1269.4% | 7,899 | +827.1% | 0.00% | – |
| Q4 2018 | $11,894,000 | -71.7% | 852 | -51.5% | 0.00% | – |
| Q3 2018 | $42,039,000 | +32.2% | 1,756 | +3.9% | 0.00% | – |
| Q2 2018 | $31,806,000 | -50.3% | 1,690 | -75.5% | 0.00% | – |
| Q1 2018 | $64,028,000 | +6.9% | 6,907 | +3.7% | 0.00% | – |
| Q4 2017 | $59,873,000 | +42.1% | 6,660 | +103.7% | 0.00% | – |
| Q3 2017 | $42,137,000 | +13.1% | 3,269 | -4.7% | 0.00% | – |
| Q2 2017 | $37,261,000 | +673.7% | 3,431 | +531.9% | 0.00% | – |
| Q1 2017 | $4,816,000 | -51.5% | 543 | -36.0% | 0.00% | – |
| Q4 2016 | $9,930,000 | -58.8% | 848 | -60.9% | 0.00% | – |
| Q3 2016 | $24,098,000 | +95.3% | 2,169 | +112.0% | 0.00% | – |
| Q2 2016 | $12,337,000 | -34.1% | 1,023 | -41.0% | 0.00% | – |
| Q4 2015 | $18,728,000 | -7.0% | 1,734 | -6.6% | 0.00% | – |
| Q3 2015 | $20,138,000 | – | 1,856 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 797,436 | $35,286,543 | 33.31% |
| Kynam Capital Management, LP | 3,003,668 | $132,912,309 | 21.74% |
| Eversept Partners, LP | 2,492,636 | $110,299,143 | 9.33% |
| Sofinnova Investments, Inc. | 3,100,560 | $137,199,780 | 8.66% |
| Eagle Health Investments LP | 595,694 | $26,359,460 | 5.81% |
| BEACONLIGHT CAPITAL, LLC | 259,865 | $11,499,026 | 4.97% |
| Lagoda Investment Management, L.P. | 165,465 | $7,321,826 | 4.81% |
| Tri Locum Partners LP | 274,795 | $12,159,679 | 3.89% |
| Bain Capital Life Sciences Investors, LLC | 700,197 | $30,983,717 | 3.46% |
| SAMLYN CAPITAL, LLC | 4,400,226 | $194,710,000 | 3.18% |